14.02.2019 19:45:00

Global Microarray Analysis Market Report 2018-2023 Featuring Thermo Fisher Scientific, Agilent Technologies, Molecular Devices, PerkinElmer, Illumina, GE, and Bio-Rad Labs

DUBLIN, Feb. 14, 2019 /PRNewswire/ --

The "Microarray Analysis Market by Product & Service (Consumables, Instrument, Software, Services), Type, Application (Research), End User (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The global microarray analysis market is expected to reach USD 5.52 billion by 2023 from USD 3.82 billion in 2018, at a CAGR of 7.6%.

The major factors driving the growth of this market are the increasing incidence of cancer, increasing funding for genomic and proteomic research, and growing application areas of microarrays.

By product and service, the market is segmented into consumables, software & services, instruments. In 2018, the consumables segment is estimated to command the largest share of the microarray analysis market. The large share of this segment can be attributed to the growing applications of microarray in various fields and the regular, repeated, & bulk purchases of consumables.

On the basis of type, the market has been segmented into DNA microarrays, protein microarrays, and other microarrays. DNA microarrays are expected to account for the largest share of the microarray analysis market in 2018. The large share of this segment can be attributed to the use of DNA microarrays in various applications such as drug discovery, genomic and cancer research, personalized medicine, and genetic disease diagnosis.

Based on application, the market has been segmented into research applications, disease diagnostics, drug discovery, and other applications. In 2018, the research applications segment is projected to account for the largest share of the market. Increasing private and government funding for genomic and proteomic research is the major driving factor for this market.

The end user segment categorized into research and academic institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. In 2018, research and academic institutes are expected to command the largest market share of this market. Increasing funding and growing initiatives by governments to support genomics and proteomics research projects is a key factor driving the growth of the research and academic institutes segment.

The market is dominated by North America, followed by Europe. North America will continue to dominate the market during the forecast period. The increasing incidence of various diseases such as cancer and genetic diseases in this region and increasing funding for genomics and proteomics research in this region are the major factors supporting the growth of the microarray analysis market in North America.

The emergence of NGS as an effective alternative to the microarray technology may hinder the growth of the market to a certain extent.

The major players in the microarray analysis market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Molecular Devices (US), PerkinElmer Inc. (US), Illumina, Inc. (US), GE Healthcare (US), and Bio-Rad Laboratories Inc. (US).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Microarray Analysis Market Overview
4.2 Asia Pacific: Market, By Product & Service (2018)
4.3 Market, By Region (2018)
4.4 Geographical Snapshot of the Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Incidence of Cancer
5.2.1.2 Growth in Funding for Genomic and Proteomic Research
5.2.1.3 Growing Application Areas of Microarrays
5.2.2 Opportunities
5.2.2.1 Use of Microarrays in Personalized Medicine
5.2.3 Challenges
5.2.3.1 Growing Adoption of Next-Generation Sequencing

6 Microarray Analysis Market, By Product and Service
6.1 Introduction
6.2 Consumables
6.3 Software and Services
6.4 Instruments

7 Microarray Analysis Market, By Type
7.1 Introduction
7.2 Dna Microarrays
7.3 Protein Microarrays
7.4 Other Microarrays

8 Microarray Analysis Market, By Application
8.1 Introduction
8.2 Research Applications
8.3 Drug Discovery
8.4 Disease Diagnostics
8.5 Other Applications

9 Microarray Analysis Market, By End User
9.1 Introduction
9.2 Research & Academic Institutes
9.3 Pharmaceutical & Biotechnology Companies
9.4 Diagnostic Laboratories
9.5 Other End Users

10 Microarray Analysis Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 Rest of Asia Pacific
10.5 Rest of the World

11 Competitive Landscape
11.1 Overview
11.2 Market Ranking Analysis, 2017
11.3 Competitive Scenario
11.3.1 Expansions
11.3.2 Acquisitions
11.3.3 Agreements
11.3.4 Product Launches and Approvals

12 Company Profiles
12.1 Thermo Fisher Scientific
12.2 Agilent Technologies
12.3 Illumina
12.4 Perkinelmer, Inc.
12.5 Merck KGaA
12.6 GE Healthcare
12.7 Molecular Devices (A Subsidiary of Danaher)
12.8 Arrayit Corporation
12.9 Bio-Rad Laboratories
12.10 Microarrays, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/c4t4s5/global_microarray?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-microarray-analysis-market-report-2018-2023-featuring-thermo-fisher-scientific-agilent-technologies-molecular-devices-perkinelmer-illumina-ge-and-bio-rad-labs-300796068.html

SOURCE Research and Markets

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!